Page 73 - Looking Statements News Today

Full Year 2023 Highlights and 2024 Guidance Revenue: $739 million, a 6% year-over-year increase Orders: $724 million and book-to-bill ratio of 98% Net loss: $19 million, or diluted EPS of...

$251 million of Total revenue in 2023 $139 million in Cell Engineering services revenue, representing 31% growth over 2022 78 new Cell Programs added in 2023, representing 32% growth over 2022 and...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced today that the Company has signed a settlement and license agreement with Janssen Biotech Inc., and Johnson & Johnson (collectively known as Janssen) that clears the way to commercialize its Bmab 1200, a proposed biosimilar to Stelara®, in the United States of America.

Forum Energy Technologies, Inc. today announced fourth quarter 2023 revenue of $185 million, a $6 million increase from the third quarter. The fourth quarter net loss was $17 million, or $1.64 per diluted share, compared to third quarter net income...

WWE's parent company TKO Group Holdings released the following today:

The Ginkgo Technology Network brings together over 25 diverse partners across an array of capabilities including AI, genetic medicines, biologics, and manufacturing. As a Ginkgo Technology...

EQS-News: AUTO1 Group SE / Key word: Annual Results/Quarter Results AUTO1 Group reports record gross profit in 2023 and best annual adjusted EBITDA since IPO 28.02.2024 /...

BOSTON, Feb. 28, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, announced that in connection to its transaction with...

Bradda Head Lithium Ltd Announces Claim Exchange Completed at Wikieup

-- Femasys readies for the commercial launch of FemaSeed® in the U.S. amidst the uncertainty following the Alabama Supreme Court Ruling on how to handle embryos used for in vitro fertilization -- ...